› 6vif

X-ray diffraction
2.26Å resolution

Human LRH-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator TIF-2

Released:
DOI: 10.2210/pdb6vif/pdb
PDB entry 6vif coloured by chain, front view.
PDB entry 6vif coloured by chain, side view.
PDB entry 6vif coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition.
Cornelison JL, Cato ML, Johnson AM, D'Agostino EH, Melchers D, Patel AB, Mays SG, Houtman R, Ortlund EA, Jui NT
Bioorg Med Chem Lett 30 127293 (2020)
PMID: 32631515

Function and Biology Details

Biochemical function:
Biological process:
  • not assigned
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
hetero dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-126310 (preferred)
Entry contents:
2 distinct polypeptide molecules
Macromolecules (2 distinct):
Nuclear receptor subfamily 5 group A member 2 Chain: A
Molecule details ›
Chain: A
Length: 245 amino acids
Theoretical weight: 28.33 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli BL21(DE3)
UniProt:
  • Canonical: O00482 (Residues: 299-541; Coverage: 45%)
Gene names: B1F, CPF, FTF, NR5A2
Sequence domains: Ligand-binding domain of nuclear hormone receptor
Nuclear receptor coactivator 2 Chain: B
Molecule details ›
Chain: B
Length: 14 amino acids
Theoretical weight: 1.71 KDa
Source organism: Homo sapiens
Expression system: Not provided
UniProt:
  • Canonical: Q15596 (Residues: 740-753; Coverage: 1%)
Gene names: BHLHE75, NCOA2, SRC2, TIF2

Ligands and Environments

1 bound ligand:
Ligand QY4 1 x QY4
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: APS BEAMLINE 22-ID
Spacegroup: P43212
Unit cell:
a: 46.134Å b: 46.134Å c: 223.436Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.242 0.24 0.284
Expression systems:
  • Escherichia coli BL21(DE3)
  • Not provided

Quick links

Citations

1 review citation

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.
Petrescu et al. (2021)
6 other articles

1 mention without citation

Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition.
Cornelison et al. (2020)